Bamidele, Nathan http://orcid.org/0000-0001-9051-5531
Zhang, Han
Dong, Xiaolong
Cheng, Haoyang
Gaston, Nicholas http://orcid.org/0000-0002-3862-9002
Feinzig, Hailey http://orcid.org/0009-0002-0087-3218
Cao, Hanbing
Kelly, Karen
Watts, Jonathan K. http://orcid.org/0000-0001-5706-1734
Xie, Jun http://orcid.org/0000-0001-9565-1567
Gao, Guangping http://orcid.org/0000-0003-0097-9012
Sontheimer, Erik J. http://orcid.org/0000-0002-0881-0310
Article History
Received: 12 April 2023
Accepted: 4 February 2024
First Online: 17 February 2024
Competing interests
: The authors declare competing financial interests. The authors have filed patent applications on technologies related to this work. G.G. is a scientific co-founder of Voyager Therapeutics, Adrenas Therapeutics, and Aspa Therapeutics and holds equity in these companies. G.G. is an inventor on patents with potential royalties licensed to Voyager Therapeutics, Aspa Therapeutics, and other biopharmaceutical companies. E.J.S. is a co-founder and scientific advisor of Intellia Therapeutics and a scientific advisor of Tessera Therapeutics. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declare no competing non-financial interests.